A new synthesis process for the key intermediate of montelukast sodium

The synthesis process of sodium montelukast intermediate is simplified by using the coupling reaction of borate group and halogen group and the acyl chloride step, which solves the problems of low yield and complicated steps in the existing technology, and achieves the goal of high yield and purity, making it suitable for industrial production.

CN116514711BActive Publication Date: 2024-11-01JIANGSU ALPHA PHARM CO LTD
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202310480848.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-04-28
Publication Date
2024-11-01
Estimated Expiration
2043-04-28

AI Technical Summary

Technical Problem

Existing synthetic routes for key intermediates of montelukast sodium have low yields, are cumbersome, and are not suitable for industrial production.

Method used

Montelukast sodium intermediate was synthesized through a four-step reaction by using a coupling reaction of borate group and halogenated group, combined with acyl chloride and dehydrating agent, which improved reaction stability and selectivity and reduced byproducts.

Benefits of technology

It simplifies the operation process, increases yield and purity, reduces waste, meets the requirements of green chemistry, and is suitable for industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116514711B_ABST
    Figure CN116514711B_ABST
Patent Text Reader

Abstract

The invention discloses a novel synthesis process of a key intermediate of montelukast sodium, wherein 2-(methoxycarbonyl)phenylboronic acid and 3-chloropropionic acid are reacted under the action of an alkaline reagent and a catalyst through a coupling reaction between a boronic acid group and a halide to obtain compound III; the compound III obtained by the reaction is chlorinated with a chlorinating agent to obtain a chlorinated product compound IV; compound V reacts with compound VI to obtain compound VII; reactant IV is dissolved in an organic solvent, reactant VII obtained in the third step is added to the solution, an organic base and a catalyst are added, and the reaction is heated to obtain a target product, montelukast sodium intermediate compound VIII. The beneficial effects of the invention are as follows: the invention improves reaction stability, increases reaction selectivity, and reduces by-product generation through a coupling reaction between a boronic acid group, a halide group and an acyl chloride, and the technical solution of the invention is simple to operate, the reaction product is easy to separate, the reaction steps are few, the yield is high, and it is suitable for the needs of industrial production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field related to the synthesis of pharmaceutical intermediates, in particular to: Background Art

[0002] The chemical name of Montelukast Sodium is: 1-(((1-(R)-(3-(2-(7-chloro-2-quinolyl)-vinyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio))methyl)cyclopropyl acetate sodium, the structural formula is as follows:

[0003]

[0004] (E)-2-[3-[3-[2-(7-chloro-2-quinolyl)vinyl]phenyl]-3-oxopropyl]benzoic acid methyl ester is a key intermediate in the currently reported process for synthesizing montelukast sodium. Its chemical structure is shown below:

[0005] .

[0006] At present, there are two main synthetic routes for this key intermediate:

[0007] Route 1: Merck's Montelukast synthesis process

[0008]

[0009] Route 2: Lunan Pharmaceutical Group's synthetic process route

[0010]

[0011] Route 1 is to use isophthalaldehyde and 7-chloro-2-methylquinoline as initial raw materials, to generate 3-[(E)-2-(7-chloroquinoline)vinyl]benzaldehyde through condensation, and then react with Grignard reagent vinylmagnesium bromide, and finally react with methyl o-bromobenzoate through Heck reaction under the catalysis of palladium acetate to generate the compound of formula (II), such as J.Org.Chem.58(1993)3731; WO 2008058118A1 both adopt this method; this route has a low yield, a long route, and troublesome post-processing of the product, and is not suitable for industrial production.

[0012] Route 2 uses isophthalaldehyde and 7-chloro-2-methylquinoline as initial raw materials, which are condensed with 3-cyanobenzaldehyde to obtain nitrile compound B1 (3-[(E)-2-(7-chloroquinolyl)vinyl]benzonitrile), and nitrile compound B1 reacts with compound B2 treated with a Grignard reagent to obtain key intermediate compound B3 (methyl (E)-2-[3-[3-[2-(7-chloro-2-quinolyl)vinyl]phenyl]-3-oxopropyl]benzoate). Compound B2 required for this route needs to be prepared separately, and there are many steps for preparing compound B2. Therefore, the overall process steps of the route are many, the production cycle is long, the cost is high, and the overall yield of this route is not high, which is not suitable for industrial production. Summary of the invention

[0013] In view of the above shortcomings, the present invention aims to provide a new synthesis process of a key intermediate of montelukast sodium, which improves reaction stability, increases reaction selectivity, and reduces the generation of by-products through the coupling reaction of a boric acid group with a halide group and an acyl chloride. The technical solution provided by the present invention is simple to operate, the reaction product is easy to separate, the reaction steps are few, the yield is high, and it is suitable for the needs of industrial production. The technical solution of the present invention is as follows:

[0014] A novel process for synthesizing a key intermediate of montelukast sodium comprises the following steps:

[0015] In the first step, 2-(methoxycarbonyl)phenylboronic acid is dissolved in an organic solvent, 3-chloropropionic acid is added dropwise, and the coupling reaction between the boronic acid group and the halide group is carried out in the presence of an alkali reagent and a catalyst to obtain compound III;

[0016] The second step is to chlorinate the compound III obtained in the first step with a chlorinating agent to obtain the chlorinated product compound IV;

[0017] The third step is to dissolve compound V in an organic solvent, add compound VI, add a dehydrating agent, heat and catalyze the reaction, and after the reaction is completed, separate the product to obtain compound VII;

[0018] In the fourth step, the reactant IV obtained in the second step is dissolved in a solvent, and the reactant VII obtained in the third step is added to the solution, and an organic base and a catalyst are added, and the mixture is heated to react. After the reaction is completed, the product is separated to obtain the target product, montelukast sodium intermediate compound VIII.

[0019] Furthermore, the solvent used in the first step reaction is tert-butanol, the organic base used is potassium tert-butoxide, the catalyst used is a complex of palladium acetate and tert-butyldimethylphosphine, and the molar ratio of the complex of palladium acetate and tert-butyldimethylphosphine is 1:2.

[0020] Furthermore, the amount of the catalyst in the first step reaction is 3-8%, preferably 5%, of the molar amount of the boric acid compound, and the molar ratio of the first step reaction compound II: reaction compound I: alkaline reagent is 1:1-1.2:2.5-3.5, preferably 1:1.1:3.

[0021] Furthermore, the chlorinating agent used in the second step reaction is one of thionyl chloride, sulfuryl chloride, phosphorus oxychloride and phosphorus trichloride, preferably thionyl chloride.

[0022] Furthermore, the solvent used in the third step reaction is one of acetic anhydride, propionic anhydride, trifluoroacetic anhydride or trichloromethanesulfonic anhydride.

[0023] Furthermore, the reaction conditions of the third step reaction are reflux reaction at 140-180° C. for 12-16 hours.

[0024] Furthermore, the catalyst used in the fourth step reaction is palladium chloride, and the amount of the catalyst palladium chloride used is 1 to 3 mol% of the reactant I, preferably 2 mol%.

[0025] Furthermore, the molar ratio of reactant IV to reactant VII in the fourth step reaction is 1:1.

[0026] Furthermore, the solvent used in the fourth step reaction is an aqueous solution of sodium dodecyl sulfonate, and the alkaline reagent used is potassium carbonate.

[0027] Furthermore, the concentration of the sodium dodecyl sulfate aqueous solution as the reaction solvent in the fourth step is 0.10-0.15M.

[0028] The beneficial effects of the present invention are as follows: the present invention couples the boric acid group with the halogenated group through the first reaction and the fourth reaction, the reaction stability of the boric acid group with the halogenated hydrocarbon is high, the boric acid group increases the reaction selectivity and reduces the generation of by-products; the fourth step reaction is carried out by the boric acid group reacting with the reactant of acyl chloride, the reaction is easier to carry out, and the generation of benzene isomers is effectively avoided. The technical scheme of the present invention reduces the reaction difficulty of the original process and simplifies the operation through the four-step reaction. At the same time, the reaction products obtained through the boric acid group coupling reaction are easy to separate, and the obtained products have high yield and high purity. At the same time, the synthetic process of the present invention generates less waste, the reagent recovery is simple, and it is green and environmentally friendly, which meets the requirements of green chemical industry. Therefore, the technical scheme of the present invention is suitable for industrialized expansion of production. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 Schematic diagram of the chemical structure of montelukast sodium;

[0030] Figure 2 It is a schematic diagram of the reaction process route of the present invention;

[0031] Figure 3 This is a schematic diagram of the chemical structure of the key intermediate of montelukast sodium of the present invention;

[0032] Figure 4 This is a schematic diagram of the process flow of route 1;

[0033] Figure 5 This is a schematic diagram of the process flow of route 2. DETAILED DESCRIPTION

[0034] The following will be combined with the embodiments of the present invention and the accompanying drawings to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0035] 19.8 g (0.11 mol) of 2-(methoxycarbonyl)phenylboronic acid was dissolved in 250 ml of tert-butanol, an organic solvent, and 0.3 mol of potassium tert-butoxide, a catalyst, 0.005 mol of palladium acetate, and 0.01 mol of a ligand, tert-butyldimethylphosphine, were added. The mixture was stirred and mixed. 0.1 mol of 3-chloropropionic acid was gradually added dropwise to the solution. The mixture was reacted at 40°C for 6 to 8 hours. After the reaction was completed, dilute hydrochloric acid was added to adjust the pH of the solution to neutral. The solvent was evaporated, 80 ml of toluene solvent was added, and deionized water was added for washing 2 to 3 times. The organic phase was separated and distilled under reduced pressure. The product was recrystallized with 40 ml of benzene or toluene to obtain 23.1 g of compound III with a yield of 93.9% and a purity of 98.5%.

[0036] Dissolve 24.6g (0.1mol) of compound III obtained in the first step in 80ml of chlorinating agent thionyl chloride, reflux at 75℃ for 4-6h, chlorinate to obtain chlorinated product, desolventize under reduced pressure to obtain 21.6g of compound IV, with a yield of 95.4% and a purity of 97.5%.

[0037] 17.8 g (0.1 mol) of compound V was dissolved in 200 ml of acetic anhydride, and 15.0 g (0.1 mol) of compound VI was added. The mixture was heated to reflux at 140°C for reaction. After the reaction, water was slowly added to quench the acetic anhydride. 100 ml of toluene was added for extraction. The organic matter was separated and the solvent was evaporated. The product was recrystallized with 50 ml of toluene to obtain 29.2 g of compound VII with a yield of 94.1% and a purity of 97.2%.

[0038] 22.7 g (0.1 mol) of the reactant IV obtained in the second step was dissolved in 200 ml of a 0.1-0.15 M sodium dodecylsulfonate aqueous solution of the solvent, 0.1 mol of the reactant VII obtained in the third step was added to the solution, 0.1 mol of potassium carbonate was added, 0.002 mol of palladium chloride catalyst was added, and the reaction was heated to 60°C for 6 hours. After the reaction was completed, dilute hydrochloric acid was added to neutralize the solution to neutrality, 100 ml of toluene was added for extraction, the organic matter was separated, saturated brine and deionized water were added for washing 2-3 times, the solvent was evaporated, and the product was recrystallized with 50 ml of acetone to obtain 43.1 g of the target product, montelukast sodium intermediate, compound VIII, with a yield of 94.4% and a purity of 97.3%.

[0039] The amount of 2-(methoxycarbonyl)phenylboronic acid in Example 1 was adjusted to 0.1 mol, and the other operations remained unchanged to obtain 23.0 g of product with a yield of 93.4% and a purity of 97.9%.

[0040] The amount of 2-(methoxycarbonyl)phenylboronic acid in Example 1 was adjusted to 0.12 mol, and the other operations remained unchanged to obtain 23.5 g of product with a yield of 94.6% and a purity of 97.9%.

[0041] The amount of potassium tert-butoxide in Example 1 was adjusted to 2.5 eq, and the other operations remained unchanged to obtain 22.8 g of product with a yield of 92.6% and a purity of 96.9%.

[0042] The amount of potassium tert-butoxide in Example 1 was adjusted to 3.5 eq, and the other operations remained unchanged. The product was 23.0 g, with a yield of 93.4% and a purity of 97.1%.

[0043] The chlorinating agent in Example 2 was adjusted to sulfuryl chloride, and the other operations remained unchanged to obtain 21.2 g of product with a yield of 93.6% and a purity of 97.3%.

[0044] The solvent and catalyst in Example 3 were adjusted to propionic anhydride, the temperature was adjusted to 170° C., and the other operations remained unchanged to obtain 23.9 g of product with a yield of 93.1% and a purity of 96.9%.

[0045] The amount of catalyst in Example 4 was adjusted to 0.001 mol, the temperature was adjusted to 170° C., and the other operations remained unchanged to obtain 42.2 g of product with a yield of 92.4% and a purity of 97.5%.

[0046] The amount of catalyst in Example 4 was adjusted to 0.003 mol, the temperature was adjusted to 170° C., and the other operations remained unchanged to obtain 42.8 g of product with a yield of 93.7% and a purity of 97.3%.

[0047] Comparative Document (CN104496899B) Example

[0048] The compound of formula (III) (2 g, 11.26 mmol) and the compound of formula (IV) (3.14 g, 13.51 mmol) were dissolved in acetic anhydride (20 mL), heated to 50°C, stirred overnight and concentrated. The concentrate was cooled and poured into ice water. It was stirred for 15 minutes. A large amount of sulfonic green solid precipitated. It was filtered and the filter cake was washed with dilute sodium carbonate aqueous solution, water, ethyl acetate and petroleum ether (1:10) in turn to obtain a compound of formula (V) (3.5 g, 80% yield).

[0049] The compound of formula (VI) (5 g, 18.1 mmol), sodium bicarbonate (3.8 g, 45.3 mmol), tetrabutylammonium bromide (5.83 g, 18.1 mmol) and anhydrous magnesium sulfate (4.5 g) were dissolved in DMF (70 mL), and then palladium acetate (406 mg, 1.81 mmol) and the compound of formula (VII) acrylol (1.58 g, 27.2 mmol) were added under nitrogen protection. The solution was heated to 50°C and stirred overnight. Ethyl acetate (100 mL) was added and stirred for 20 minutes. Insoluble matter was removed by filtration. Water (100 mL) was added and extracted with ethyl acetate for 3 times. The mixture was washed with saturated sodium chloride, concentrated, redissolved in ethyl acetate, decolorized with activated carbon, and concentrated to obtain the product (3.48 g, 92.5% yield).

[0050] The above-synthesized compound of formula (V) (900 mg, 2.30 mmol), compound of formula (VIII) (948 mg, 4.6 mmol), tetrabutylammonium bromide (741 mg, 2.30 mmol) and anhydrous magnesium sulfate (3 g) were dissolved in DMF (12 mL). Palladium acetate (51 mg, 0.23 mmol) and pyrrolidine (489 mg, 6.9 mmol) were added to the resulting solution under nitrogen protection. The solution was heated to 50° C. and stirred for 4 hours. Water (50 mL) was added and extracted with ethyl acetate for 3 times, then washed with saturated sodium chloride, concentrated, purified by column chromatography (petroleum ether: ethyl acetate = 10:1), and concentrated to obtain a compound of formula (II) (786 mg, 73% yield).

[0051] In summary, the total yield of the embodiments of the comparative documents is about 55%, and the comprehensive yield of the present invention is higher than 70%. Compared with the prior art, the technical solution of the present invention has better reaction stability, better reaction selectivity, and fewer by-products. In addition, the technical solution of the present invention is simple to operate, the reaction products are easy to separate, the reaction steps are few, and the yield is high, which is suitable for the needs of industrial production.

[0052] It will be apparent to those skilled in the art that the invention is not limited to the details of the exemplary embodiments described above and that the invention can be implemented in other specific forms without departing from the spirit or essential features of the invention. Therefore, the embodiments should be considered exemplary and non-limiting in all respects, and the scope of the invention is defined by the appended claims rather than the foregoing description, and it is intended that all variations falling within the meaning and scope of the equivalent elements of the claims be included in the invention. Any reference numeral in a claim should not be considered as limiting the claim to which it relates.

[0053] In addition, it should be understood that although the present specification is described according to implementation modes, not every implementation mode contains only one independent technical solution. This description of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment may also be appropriately combined to form other implementation modes that can be understood by those skilled in the art.

Claims

1. A new process for synthesizing a key intermediate of montelukast sodium, Features The following steps are involved: In the first step, 2-(methoxycarbonyl)phenylboronic acid is dissolved in an organic solvent, 3-chloropropionic acid is added dropwise, and the coupling reaction between the boronic acid group and the halide group is carried out in the presence of an alkali reagent and a catalyst to obtain compound III; The second step is to chlorinate the compound III obtained in the first step with a chlorinating agent to obtain the chlorinated product compound IV; The third step is to dissolve compound V in an organic solvent, add compound VI, add a dehydrating agent, heat and catalyze the reaction, and after the reaction is completed, separate the product to obtain compound VII; In the fourth step, the reactant IV obtained in the second step is dissolved in a solvent, and the reactant VII obtained in the third step is added to the solution, potassium carbonate and a catalyst are added, and the mixture is heated to react. After the reaction is completed, the product is separated to obtain the target product, montelukast sodium intermediate compound VIII.

2. A novel process for synthesizing a key intermediate of montelukast sodium according to claim 1, Features: The solvent used in the first step reaction is tert-butanol, the alkaline reagent used is potassium tert-butoxide, and the catalyst used is a complex of palladium acetate and tert-butyldimethylphosphine. The molar ratio of palladium acetate to tert-butyldimethylphosphine in the complex is 1:

2.

3. A novel process for synthesizing a key intermediate of montelukast sodium according to claim 1, Features: The amount of the catalyst used in the first step reaction is 5% of the molar amount of compound I, and the molar ratio of compound II: compound I: alkaline reagent in the first step reaction is 1:1-1.2:2.5-3.

5.

4. A novel process for synthesizing a key intermediate of montelukast sodium according to claim 1, Features: The chlorinating agent used in the second step reaction is one of thionyl chloride, sulfuryl chloride, phosphorus oxychloride or phosphorus trichloride.

5. A novel process for synthesizing a key intermediate of montelukast sodium according to claim 1, Features: The reaction conditions of the third step reaction are reflux reaction at 140-180° C. for 12-16 hours.

6. A novel process for synthesizing a key intermediate of montelukast sodium according to claim 1, Features: The catalyst for the fourth step reaction is palladium chloride, and the amount used is 1-3 mol% of the reactant IV.

7. A novel process for synthesizing a key intermediate of montelukast sodium according to claim 1, Features: The solvent and dehydrating agent used in the third step reaction are one of acetic anhydride, propionic anhydride, trifluoroacetic anhydride or trichloromethanesulfonic anhydride.

8. A novel process for synthesizing a key intermediate of montelukast sodium according to claim 1, Features: The molar ratio of reactant IV to reactant VII in the fourth step reaction is 1:

1.

9. A novel process for synthesizing a key intermediate of montelukast sodium according to claim 1, Features: The solvent used in the fourth step reaction is sodium dodecyl sulfate aqueous solution.

10. A novel process for synthesizing a key intermediate of montelukast sodium according to claim 1, Features: The fourth step reaction solvent is sodium dodecyl sulfonate aqueous solution with a concentration of 0.10-0.15M.

Citation Information

Patent Citations

  • The synthetic method of the intermediate of montelukast sodium

    CN104496899B

  • Preparation of montelukast and its salts

    WO2008058118A2

  • Molecular fluorescent probe for detecting hypochlorite and preparation and application thereof

    CN102977130A

  • Synthesis method of midbody of Montelukast sodium

    CN104496899A

  • Polymers and oligomers with aggregation-induced emission characteristics for imaging and image-guided therapy

    CN106470964A